Skip to main content

Table 2 Percentage of participants reporting level 1–5 for each EQ-5D-5 L dimension by disease group

From: Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia

EQ-5D-5 L dimensions

Distribution of responses n (%)

 

Diagnosis

 

OI

FD

XLH

Total

Mobility

 No problems

8 (19)

18 (43)

3 (13)

29 (27)

 Slight problems

14 (33)

9 (21)

10 (42)

33 (30)

 Moderate problems

10 (23)

8 (19)

6 (25)

24 (22)

 Severe problems

6 (14)

7 (17)

2 (8)

15 (14)

 Extreme problems

5 (12)

0 (0)

3 (13)

8 (7)

Self-care

 No problems

26 (61)

26 (62)

12 (50)

64 (59)

 Slight problems

10 (23)

11 (26)

7 (29.)

28 (26)

 Moderate problems

3 (7)

4 (10)

1 (4)

8 (7)

 Severe problems

2 (5)

1 (3)

2 (8)

5 (5)

 Extreme problems

2 (5)

0 (0)

2 (8)

4 (4)

Usual activity

 No problems

15 (35)

14 (33)

6 (25)

35 (32)

 Slight problems

13 (30)

13 (31)

10 (42)

36 (33)

 Moderate problems

8 (19)

8 (19)

5 (21)

21 (19)

 Severe problems

5 (12)

4 (10)

3 (13)

12 (11)

 Extreme problems

2 (5)

3 (7)

0 (0)

5 (5)

Pain/Discomfort

 No problems

3 (7)

1 (2)

2 (8)

6 (6)

 Slight problems

14 (33)

13 (31)

6 (25)

33 (30)

 Moderate problems

19 (44)

15 (36)

10 (42)

44 (40)

 Severe problems

4 (9)

9 (21)

5 (21)

18 (17)

 Extreme problems

3 (7)

4 (10)

1 (4)

8 (7)

Anxiety/Depression

 No problems

17 (40)

16 (38)

10 (42)

43 (39)

 Slight problems

17 (40)

12 (29)

13 (54)

42 (39)

 Moderate problems

6 (14)

10 (24)

1 (4)

17 (16)

 Severe problems

3 (7)

4 (10)

0 (0)

7 (6)

 Extreme problems

0 (0

0 (0)

0 (0)

0 (0)